StartUp Health – Sinaptica Therapeutics: Bridging Neuroscience Gaps to Slow the Progression of Alzheimer’s Disease

* Disclaimer: Sinaptica Therapeutics™ is currently in development and has not received market authorization for sale in the US, Canada, or any other geography.